Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease
Vivek Narayan, Elizabeth Thompson, Biniyam G. Demissei, et al.
Journal of the American College of Cardiology (2020) Vol. 75, Iss. 21, pp. 2726-2737
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold, et al.
Circulation (2023) Vol. 148, Iss. 9
Open Access | Times Cited: 587
Hallmarks of Health
Carlos López‐Otín, Guido Kroemer
Cell (2020) Vol. 184, Iss. 1, pp. 33-63
Open Access | Times Cited: 377
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease
Salim S. Virani, L. Kristin Newby, Suzanne V. Arnold, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 9, pp. 833-955
Open Access | Times Cited: 217
Cardiovascular Risk Factors Are Associated With Future Cancer
Emily S. Lau, Samantha M. Paniagua, Elizabeth Liu, et al.
JACC CardioOncology (2021) Vol. 3, Iss. 1, pp. 48-58
Open Access | Times Cited: 143
Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence
Nabil V. Sayour, Ágnes Paál, Pietro Ameri, et al.
European Heart Journal (2024) Vol. 45, Iss. 14, pp. 1224-1240
Open Access | Times Cited: 19
Small Extracellular Vesicles From Infarcted and Failing Heart Accelerate Tumor Growth
Tal Caller, Itai Rotem, Olga Shaihov–Teper, et al.
Circulation (2024) Vol. 149, Iss. 22, pp. 1729-1748
Closed Access | Times Cited: 18
Therapeutic targeting of BAG3: considering its complexity in cancer and heart disease
Jonathan A. Kirk, Joseph Y. Cheung, Arthur M. Feldman
Journal of Clinical Investigation (2021) Vol. 131, Iss. 16
Open Access | Times Cited: 56
The Effect of Ketogenic Diet on Shared Risk Factors of Cardiovascular Disease and Cancer
Noushin Mohammadifard, Fahimeh Haghighatdoost, Mehran Rahimlou, et al.
Nutrients (2022) Vol. 14, Iss. 17, pp. 3499-3499
Open Access | Times Cited: 49
Human Milk Extracellular Vesicles: A Biological System with Clinical Implications
Somchai Chutipongtanate, Ardythe L. Morrow, David S. Newburg
Cells (2022) Vol. 11, Iss. 15, pp. 2345-2345
Open Access | Times Cited: 45
Melanoma and microbiota: Current understanding and future directions
Bertrand Routy, Tanisha Jackson, Laura Mählmann, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 16-34
Open Access | Times Cited: 31
Jiawei Yanghe Decoction suppresses breast cancer by regulating immune responses via JAK2/STAT3 signaling pathway
Yanting You, Xiaomei Chen, Xiaohu Chen, et al.
Journal of Ethnopharmacology (2023) Vol. 316, pp. 116358-116358
Closed Access | Times Cited: 25
Advances in pathogenesis of preeclampsia
Mei Yang, Menghui Wang, Nanfang Li
Archives of Gynecology and Obstetrics (2024) Vol. 309, Iss. 5, pp. 1815-1823
Closed Access | Times Cited: 16
Complications and comorbidities associated with antineoplastic chemotherapy: Rethinking drug design and delivery for anticancer therapy
Xiaoman Mao, Shuang Wu, Dandan Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2901-2926
Open Access | Times Cited: 9
Unveiling the “common soil” of cardiovascular disease and cancer
Licia Iacoviello, Chiara Cerletti
Bleeding Thrombosis and Vascular Biology (2025) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Association of Initial and Longitudinal Changes in C-reactive Protein With the Risk of Cardiovascular Disease, Cancer, and Mortality
Navin Suthahar, Dongyu Wang, Joseph Pierre Aboumsallem, et al.
Mayo Clinic Proceedings (2023) Vol. 98, Iss. 4, pp. 549-558
Open Access | Times Cited: 20
Machine Learning Application in Horticulture and Prospects for Predicting Fresh Produce Losses and Waste: A Review
Ikechukwu Kingsley Opara, Umezuruike Linus Opara, Jude A. Okolie, et al.
Plants (2024) Vol. 13, Iss. 9, pp. 1200-1200
Open Access | Times Cited: 7
Air Pollution in Cardio-Oncology and Unraveling the Environmental Nexus
Wenqiang Zhu, Sadeer Al‐Kindi, Sanjay Rajagopalan, et al.
JACC CardioOncology (2024) Vol. 6, Iss. 3, pp. 347-362
Open Access | Times Cited: 6
Volatile organic compounds and mortality from ischemic heart disease: A case-cohort study
Mahdi Nalini, Hossein Poustchi, Deepak Bhandari, et al.
American Journal of Preventive Cardiology (2024) Vol. 19, pp. 100700-100700
Open Access | Times Cited: 6
Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases
Angelo Michele de Candia, Diane Xavier de Ávila, Gustavo Rodolfo Moreira, et al.
American Heart Journal Plus Cardiology Research and Practice (2021) Vol. 9, pp. 100046-100046
Open Access | Times Cited: 38
Role of Cardiac Biomarkers in Cancer Patients
Gennaro Carmine Semeraro, Carlo M. Cipolla, Daniela Cardinale
Cancers (2021) Vol. 13, Iss. 21, pp. 5426-5426
Open Access | Times Cited: 33
DNA damage response signaling: A common link between cancer and cardiovascular diseases
Sepideh Nikfarjam, Krishna K. Singh
Cancer Medicine (2022) Vol. 12, Iss. 4, pp. 4380-4404
Open Access | Times Cited: 24
Isorhamnetin: A Novel Natural Product Beneficial for Cardiovascular Disease
Wenqing Li, Jing Li, Wenxiu Liu, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 31, pp. 2569-2582
Closed Access | Times Cited: 23
Circulating Cardiovascular Biomarkers in Cancer Therapeutics‐Related Cardiotoxicity: Review of Critical Challenges, Solutions, and Future Directions
Gillian Murtagh, James L. Januzzi, Marielle Scherrer‐Crosbie, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 21
Open Access | Times Cited: 14
Olive oil consumption is associated with lower cancer, cardiovascular and all-cause mortality among Italian adults: prospective results from the Moli-sani Study and analysis of potential biological mechanisms
Emilia Ruggiero, Augusto Di Castelnuovo, Simona Costanzo, et al.
European Journal of Clinical Nutrition (2024)
Open Access | Times Cited: 5
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort study
Simon Kraler, Luca Liberale, Stephan Nopp, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 3125-3136
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top